Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Saunders

Showing results (251-260 of 276) with videos related to

Pageof 28
Sort By:
Bioorganic & Medicinal Chemistry Letters|August 16, 2005
Potent and orally active non-peptide antagonists of the human melanocortin-4 receptor based on a series of trans-2-disubstituted cyclohexylpiperazinesFabio C Tucci, Nicole S White, Stacy Markison, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|November 18, 2022
Detection of 10 cases of ceftriaxone-resistant <i>Neisseria gonorrhoeae</i> in the United Kingdom, December 2021 to June 2022Michaela Day, Rachel Pitt, Nisha Mody, et al.
Journal of Medicinal Chemistry|August 5, 2005
Design and synthesis of tricyclic imidazo[4,5-b]pyridin-2-ones as corticotropin-releasing factor-1 antagonistsZhiqiang Guo, John E Tellew, Raymond S Gross, et al.
AIDS (London, England)|December 7, 2023
Bone turnover change after randomized switch from tenofovir disoproxil to tenofovir alafenamide fumarate in men with HIVAmelia E B Moore, James E Burns, Deirdre Sally, et al.
The Lancet. Public Health|October 1, 2022
Accelerated partner therapy contact tracing for people with chlamydia (LUSTRUM): a crossover cluster-randomised controlled trialClaudia S Estcourt, Oliver Stirrup, Andrew Copas, et al.
Addiction (Abingdon, England)|December 9, 2021
Brief overview of the WHO Collaborative Project on the Development of New International Screening and Diagnostic Instruments for Gaming Disorder and Gambling DisorderNatacha Carragher, Joël Billieux, Henrietta Bowden-Jones, et al.
Bioorganic & Medicinal Chemistry Letters|February 6, 2008
2,6-Diaryl-4-phenacylaminopyrimidines as potent and selective adenosine A(2A) antagonists with reduced hERG liabilityManisha Moorjani, Xiaohu Zhang, Yongsheng Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 8, 2015
Tadalafil augments tumor specific immunity in patients with head and neck squamous cell carcinomaJoseph A Califano, Zubair Khan, Kimberly A Noonan, et al.
Journal of Medicinal Chemistry|September 2, 2005
Design and synthesis of tricyclic corticotropin-releasing factor-1 antagonistsRaymond S Gross, Zhiqiang Guo, Brian Dyck, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2018
Correction: Tadalafil Augments Tumor-specific Immunity in Patients with Head and Neck Squamous Cell CarcinomaJoseph A Califano, Zubair Khan, Kimberly A Noonan, et al.
Pageof 28

Showing results (251-260 of 276) with videos related to

Sort By:
Pageof 28
Bioorganic & Medicinal Chemistry Letters|August 16, 2005
Potent and orally active non-peptide antagonists of the human melanocortin-4 receptor based on a series of trans-2-disubstituted cyclohexylpiperazinesFabio C Tucci, Nicole S White, Stacy Markison, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|November 18, 2022
Detection of 10 cases of ceftriaxone-resistant <i>Neisseria gonorrhoeae</i> in the United Kingdom, December 2021 to June 2022Michaela Day, Rachel Pitt, Nisha Mody, et al.
Journal of Medicinal Chemistry|August 5, 2005
Design and synthesis of tricyclic imidazo[4,5-b]pyridin-2-ones as corticotropin-releasing factor-1 antagonistsZhiqiang Guo, John E Tellew, Raymond S Gross, et al.
AIDS (London, England)|December 7, 2023
Bone turnover change after randomized switch from tenofovir disoproxil to tenofovir alafenamide fumarate in men with HIVAmelia E B Moore, James E Burns, Deirdre Sally, et al.
The Lancet. Public Health|October 1, 2022
Accelerated partner therapy contact tracing for people with chlamydia (LUSTRUM): a crossover cluster-randomised controlled trialClaudia S Estcourt, Oliver Stirrup, Andrew Copas, et al.
Addiction (Abingdon, England)|December 9, 2021
Brief overview of the WHO Collaborative Project on the Development of New International Screening and Diagnostic Instruments for Gaming Disorder and Gambling DisorderNatacha Carragher, Joël Billieux, Henrietta Bowden-Jones, et al.
Bioorganic & Medicinal Chemistry Letters|February 6, 2008
2,6-Diaryl-4-phenacylaminopyrimidines as potent and selective adenosine A(2A) antagonists with reduced hERG liabilityManisha Moorjani, Xiaohu Zhang, Yongsheng Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 8, 2015
Tadalafil augments tumor specific immunity in patients with head and neck squamous cell carcinomaJoseph A Califano, Zubair Khan, Kimberly A Noonan, et al.
Journal of Medicinal Chemistry|September 2, 2005
Design and synthesis of tricyclic corticotropin-releasing factor-1 antagonistsRaymond S Gross, Zhiqiang Guo, Brian Dyck, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2018
Correction: Tadalafil Augments Tumor-specific Immunity in Patients with Head and Neck Squamous Cell CarcinomaJoseph A Califano, Zubair Khan, Kimberly A Noonan, et al.
Pageof 28